Protective effect of pentoxifylline on volume-induced lung injury in newborn piglets

William E. Smalling, Cleide Suguihara, Jian Huang, Maria Rodriguez, Eduardo Bancalari

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

To evaluate the efficacy of pentoxifylline (PTXF) in the attenuation of lung inflammation during volume-induced lung injury (VILI) in newborn piglets, 17 newborn piglets were mechanically ventilated with a large tidal volume (50 ml/kg) for a period of 8 h. They were randomly assigned to a placebo (PL, n = 9) or a treatment group (PTXF, n = 8) that received PTXF (20 mg/kg as a bolus, followed by a continuous infusion of 5 mg/kg/h). Hemodynamics, lung mechanics and arterial blood gases were measured during the 8 h of study. Serum and tracheoalveolar fluid (TAF) platelet-activating factor (PAF) and thromboxane (TXB2) levels were obtained at baseline and at 8 h, while lung tissue myeloperoxidase (MPO) and wet to dry weight were assessed after the completion of the study. In the PL group, a marked increase in TAF PAF and TXB2 levels was observed only in TAF, suggesting that the inflammatory process was localized within the lungs. A significant decrease in lung tissue MPO activity (p < 0.005) and lung wet to dry weight ratio (p < 0.04) was observed in the PTXF group. There were no differences in hemodynamics, arterial blood gases or lung mechanics measurements between groups. A significant reduction in pulmonary inflammatory response was observed during VILI in the PTXF pretreated animals. These results suggest that PTXF may be effective in modulating lung inflammation associated with mechanical ventilation in neonates.

Original languageEnglish
Pages (from-to)15-21
Number of pages7
JournalBiology of the Neonate
Volume86
Issue number1
DOIs
StatePublished - Aug 27 2004

Fingerprint

Pentoxifylline
Lung Injury
Lung
Platelet Activating Factor
Mechanics
Peroxidase
Pneumonia
Gases
Hemodynamics
Weights and Measures
Thromboxanes
Tidal Volume
Pulmonary Edema
Artificial Respiration
Placebos
Serum

Keywords

  • Acute lung inflammation
  • Anti-inflammatory agents
  • Pentoxifylline
  • Volutrauma

ASJC Scopus subject areas

  • Developmental Biology
  • Pediatrics, Perinatology, and Child Health

Cite this

Protective effect of pentoxifylline on volume-induced lung injury in newborn piglets. / Smalling, William E.; Suguihara, Cleide; Huang, Jian; Rodriguez, Maria; Bancalari, Eduardo.

In: Biology of the Neonate, Vol. 86, No. 1, 27.08.2004, p. 15-21.

Research output: Contribution to journalArticle

Smalling, William E. ; Suguihara, Cleide ; Huang, Jian ; Rodriguez, Maria ; Bancalari, Eduardo. / Protective effect of pentoxifylline on volume-induced lung injury in newborn piglets. In: Biology of the Neonate. 2004 ; Vol. 86, No. 1. pp. 15-21.
@article{6860b25c30bc4970b598568368276a25,
title = "Protective effect of pentoxifylline on volume-induced lung injury in newborn piglets",
abstract = "To evaluate the efficacy of pentoxifylline (PTXF) in the attenuation of lung inflammation during volume-induced lung injury (VILI) in newborn piglets, 17 newborn piglets were mechanically ventilated with a large tidal volume (50 ml/kg) for a period of 8 h. They were randomly assigned to a placebo (PL, n = 9) or a treatment group (PTXF, n = 8) that received PTXF (20 mg/kg as a bolus, followed by a continuous infusion of 5 mg/kg/h). Hemodynamics, lung mechanics and arterial blood gases were measured during the 8 h of study. Serum and tracheoalveolar fluid (TAF) platelet-activating factor (PAF) and thromboxane (TXB2) levels were obtained at baseline and at 8 h, while lung tissue myeloperoxidase (MPO) and wet to dry weight were assessed after the completion of the study. In the PL group, a marked increase in TAF PAF and TXB2 levels was observed only in TAF, suggesting that the inflammatory process was localized within the lungs. A significant decrease in lung tissue MPO activity (p < 0.005) and lung wet to dry weight ratio (p < 0.04) was observed in the PTXF group. There were no differences in hemodynamics, arterial blood gases or lung mechanics measurements between groups. A significant reduction in pulmonary inflammatory response was observed during VILI in the PTXF pretreated animals. These results suggest that PTXF may be effective in modulating lung inflammation associated with mechanical ventilation in neonates.",
keywords = "Acute lung inflammation, Anti-inflammatory agents, Pentoxifylline, Volutrauma",
author = "Smalling, {William E.} and Cleide Suguihara and Jian Huang and Maria Rodriguez and Eduardo Bancalari",
year = "2004",
month = "8",
day = "27",
doi = "10.1159/000076917",
language = "English",
volume = "86",
pages = "15--21",
journal = "Neonatology",
issn = "1661-7800",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Protective effect of pentoxifylline on volume-induced lung injury in newborn piglets

AU - Smalling, William E.

AU - Suguihara, Cleide

AU - Huang, Jian

AU - Rodriguez, Maria

AU - Bancalari, Eduardo

PY - 2004/8/27

Y1 - 2004/8/27

N2 - To evaluate the efficacy of pentoxifylline (PTXF) in the attenuation of lung inflammation during volume-induced lung injury (VILI) in newborn piglets, 17 newborn piglets were mechanically ventilated with a large tidal volume (50 ml/kg) for a period of 8 h. They were randomly assigned to a placebo (PL, n = 9) or a treatment group (PTXF, n = 8) that received PTXF (20 mg/kg as a bolus, followed by a continuous infusion of 5 mg/kg/h). Hemodynamics, lung mechanics and arterial blood gases were measured during the 8 h of study. Serum and tracheoalveolar fluid (TAF) platelet-activating factor (PAF) and thromboxane (TXB2) levels were obtained at baseline and at 8 h, while lung tissue myeloperoxidase (MPO) and wet to dry weight were assessed after the completion of the study. In the PL group, a marked increase in TAF PAF and TXB2 levels was observed only in TAF, suggesting that the inflammatory process was localized within the lungs. A significant decrease in lung tissue MPO activity (p < 0.005) and lung wet to dry weight ratio (p < 0.04) was observed in the PTXF group. There were no differences in hemodynamics, arterial blood gases or lung mechanics measurements between groups. A significant reduction in pulmonary inflammatory response was observed during VILI in the PTXF pretreated animals. These results suggest that PTXF may be effective in modulating lung inflammation associated with mechanical ventilation in neonates.

AB - To evaluate the efficacy of pentoxifylline (PTXF) in the attenuation of lung inflammation during volume-induced lung injury (VILI) in newborn piglets, 17 newborn piglets were mechanically ventilated with a large tidal volume (50 ml/kg) for a period of 8 h. They were randomly assigned to a placebo (PL, n = 9) or a treatment group (PTXF, n = 8) that received PTXF (20 mg/kg as a bolus, followed by a continuous infusion of 5 mg/kg/h). Hemodynamics, lung mechanics and arterial blood gases were measured during the 8 h of study. Serum and tracheoalveolar fluid (TAF) platelet-activating factor (PAF) and thromboxane (TXB2) levels were obtained at baseline and at 8 h, while lung tissue myeloperoxidase (MPO) and wet to dry weight were assessed after the completion of the study. In the PL group, a marked increase in TAF PAF and TXB2 levels was observed only in TAF, suggesting that the inflammatory process was localized within the lungs. A significant decrease in lung tissue MPO activity (p < 0.005) and lung wet to dry weight ratio (p < 0.04) was observed in the PTXF group. There were no differences in hemodynamics, arterial blood gases or lung mechanics measurements between groups. A significant reduction in pulmonary inflammatory response was observed during VILI in the PTXF pretreated animals. These results suggest that PTXF may be effective in modulating lung inflammation associated with mechanical ventilation in neonates.

KW - Acute lung inflammation

KW - Anti-inflammatory agents

KW - Pentoxifylline

KW - Volutrauma

UR - http://www.scopus.com/inward/record.url?scp=4043159774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043159774&partnerID=8YFLogxK

U2 - 10.1159/000076917

DO - 10.1159/000076917

M3 - Article

VL - 86

SP - 15

EP - 21

JO - Neonatology

JF - Neonatology

SN - 1661-7800

IS - 1

ER -